A Review Of Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic outcomes stem from its conversation with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors in the central anxious program, conolidine modulates alternate molecular targets. A Science Innovations review discovered that conolidine interacts with the atypical chemokine receptor ACKR3/CXCR7, whi